BIOMAT Database Logo BIOMAT Database Logo

[Anti-HTLV-III antibodies in hemophiliacs treated with concentrates of factors VIII or IX]. 1985

J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado

UI MeSH Term Description Entries
D005164 Factor IX Storage-stable blood coagulation factor acting in the intrinsic pathway of blood coagulation. Its activated form, IXa, forms a complex with factor VIII and calcium on platelet factor 3 to activate factor X to Xa. Deficiency of factor IX results in HEMOPHILIA B (Christmas Disease). Autoprothrombin II,Christmas Factor,Coagulation Factor IX,Plasma Thromboplastin Component,Blood Coagulation Factor IX,Factor 9,Factor IX Complex,Factor IX Fraction,Factor Nine,Factor IX, Coagulation
D005169 Factor VIII Factor VIII of blood coagulation. Antihemophilic factor that is part of the factor VIII/von Willebrand factor complex. Factor VIII is produced in the liver and acts in the intrinsic pathway of blood coagulation. It serves as a cofactor in factor X activation and this action is markedly enhanced by small amounts of thrombin. Coagulation Factor VIII,Factor VIII Clotting Antigen,Factor VIII Coagulant Antigen,Factor VIII Procoagulant Activity,Thromboplastinogen,Blood Coagulation Factor VIII,F VIII-C,Factor 8,Factor 8 C,Factor Eight,Factor VIIIC,Hyate-C,Hyatt-C,F VIII C,Hyate C,HyateC,Hyatt C,HyattC
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D015483 HIV Antibodies Antibodies reactive with HIV ANTIGENS. AIDS Antibodies,HIV-Associated Antibodies,HTLV-III Antibodies,HTLV-III-LAV Antibodies,LAV Antibodies,Lymphadenopathy-Associated Antibodies,T-Lymphotropic Virus Type III Antibodies, Human,HIV Associated Antibodies,HTLV III Antibodies,HTLV III LAV Antibodies,Lymphadenopathy Associated Antibodies,T Lymphotropic Virus Type III Antibodies, Human,Antibodies, AIDS,Antibodies, HIV,Antibodies, HIV Associated,Antibodies, HIV-Associated,Antibodies, HTLV III,Antibodies, HTLV-III,Antibodies, HTLV-III-LAV,Antibodies, LAV,Antibodies, Lymphadenopathy Associated,Antibodies, Lymphadenopathy-Associated

Related Publications

J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
June 1986, Journal of medical virology,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
AIDS retrovirus antibodies in hemophiliacs treated with factor VIII or factor IX concentrates, cryoprecipitate, or fresh frozen plasma: prevalence, seroconversion rate, and clinical correlations.
March 1986, Blood,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentrates.
September 1986, Clinical immunology and immunopathology,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
HTLV-III/LAV antibodies in contacts of hemophiliacs.
June 1986, JAMA,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
[Viral hepatitis in hemophiliac patients treated with commercial concentrates of factors VIII and IX].
April 1985, Medicina clinica,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
[Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs].
April 1986, Medicina clinica,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
The prevalence of HTLV-III and HTLV-I antibodies in serum of hemophiliacs.
December 1985, Thrombosis and haemostasis,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
Anti-HTLV-III and anti-HTLV-I antibodies and T cell subsets in hemophiliacs living in HTLV-I endemic and nonendemic areas of Japan.
January 1987, Acta haematologica,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors.
August 1986, Thrombosis and haemostasis,
J A Aznar, and D Granda, and J Jorquera, and A González-Molina, and E Carmona, and A Peiró, and M Gobernado
Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
August 1980, The New England journal of medicine,
Copied contents to your clipboard!